Fig. 2From: Evolving prevalence of haematological malignancies in orphan designation procedures in the European UnionPrevalence reported for OD trends submitted to the COMP for Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Chronic Myeloid Leukaemia (CML), Hodgkin’s Lymphoma (HL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukaemia/ Small Lymphocytic Lymphoma CLL/SLL, Multiple Myeloma (MM) and Acute Myeloid Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL) between 2000 and 2015Back to article page